Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03026218 · ClinicalTrials.gov registry record · NA
Group and Mobile Care for Gestational Diabetes
A NA study, sponsored by University of Maryland, Baltimore.
- Completed
- Registry status
- NA
- Development phase
- 22
- Enrollment target
NCT03026218 is a NA study that has completed, run by University of Maryland, Baltimore. The registered enrollment target is 22 participants.
The verdict
NCT03026218, a NA study, has completed, sponsored by University of Maryland, Baltimore.
- COMPLETED
- Registry status
- NA
- Development phase
- 22 participants
- Enrollment target
Study Summary
A critical variation in the provision of prenatal care to women with GDM is the need to keep patients engaged with their care between visits by tracking glucose levels using finger sticks and making dietary and other lifestyle modifications to keep these levels at or close to normal. Multiple studies have demonstrated that the use of mobile devices can improve medical outcomes. In order to keep patients engaged between appointments and improve self-care/lifestyle, we will study the use of a glucose monitoring system with nutrition therapy called GlucoseMama(GM). GM is a mobile app on the iOS system that individuals with GDM will use to tract blood sugars and number of carbs consumed. In addition, it will give the user positive feedback and rewards for using the system. This model of group care with mobile phone monitoring and reminders for women with GDM has not been previously studied. A randomized control trial is purposed to determine if this approach improves patient care. The investigators hypothesize that group prenatal care along with inter-session mobile therapy will increase dietary compliance and therefore reduce the number of individuals requiring pharmacologic therapy and improve neonatal outcomes during pregnancy. Group prenatal care (GPC) will provide a community foundation to improve learning and increase the motivation of patients to learn and change. This motivation will be further strengthened by the use of the GlucoseMama monitoring system which will provide each patient with glucose tracking and individualized nutritional support.
Interventions
- OTHER GlucoseMama application with blood sugar monitoring and carb monitoring.
- OTHER Group prenatal care for GDM.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 22 participants |
| Start Date | 2017-04-15 |
| Est. Completion | 2019-05-15 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03026218
The ClinicalTrials.gov registry entry for NCT03026218 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 22 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Maryland, Baltimore, which has 560 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which GlucoseMama application with blood sugar monitoring and carb monitoring. is the first listed.
NCT03026218 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03026218 about?
NCT03026218 is a clinical study titled "Group and Mobile Care for Gestational Diabetes". A critical variation in the provision of prenatal care to women with GDM is the need to keep patients engaged with their care between visits by tracking glucose levels using finger sticks and making dietary and other lifestyle modifications to keep these levels at or close to normal. Multiple studie...
What is the current status of trial NCT03026218?
This trial is currently completed. It is a NA study. The enrollment target is 22 participants. The study started on 2017-04-15. Estimated completion is 2019-05-15.
What interventions are being tested in trial NCT03026218?
The interventions under investigation include: GlucoseMama application with blood sugar monitoring and carb monitoring. (OTHER), Group prenatal care for GDM. (OTHER).
Who is sponsoring clinical trial NCT03026218?
This trial is sponsored by University of Maryland, Baltimore, which has 560 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.